Showing results (1321-1330 of 7,755) with videos related to
Sort By:
Pageof 776
Pharmacological Research|October 21, 2020
Neuronal degeneration and cognitive impairment can be prevented via the normalization of mitochondrial dynamicsKaori Ishikawa, Satoshi Yamamoto, Satoko Hattori, et al.Pharmacological Research|December 24, 2022
Advancing targeted protein degradation for metabolic diseases therapyQian-Qian Zhou, Hai-Tao Xiao, Fan Yang, et al.Pharmacological Research|December 25, 2022
Lipodystrophies in non-insulin-dependent children: Treatment options and results from recombinant human leptin therapyValeria Calcaterra, Vittoria Carlotta Magenes, Virginia Rossi, et al.Pharmacological Research|December 27, 2022
Mirabegron-induced brown fat activation does not exacerbate atherosclerosis in mice with a functional hepatic ApoE-LDLR pathwayZhixiong Ying, Robin van Eenige, Rosa Beerepoot, et al.Pharmacological Research|January 20, 2023
Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metforminJing Meng, Jingxia Han, Xiaorui Wang, et al.Pharmacological Research|January 21, 2023
Diabetic retinopathy in the pediatric population: Pathophysiology, screening, current and future treatmentsAlessandro Invernizzi, Jay Chhablani, Francesco Viola, et al.Pharmacological Research|December 31, 2022
Identification and characterization of Necdin as a target for the Cockayne syndrome B protein in promoting neuronal differentiation and maintenanceFangkeng Liang, Bijuan Li, Yingying Xu, et al.Pharmacological Research|December 31, 2022
Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodiesBruno P Imbimbo, Stefania Ippati, Mark Watling, et al.Pharmacological Research|January 23, 2023
Inhibition of Drp1-dependent mitochondrial fission by natural compounds as a therapeutic strategy for organ injuriesSohrab Rahmani, Ali Roohbakhsh, Gholamreza KarimiPharmacological Research|January 24, 2023
Galanin receptor 3 - A new pharmacological target in retina degenerationJoseph T Ortega, Tanu Parmar, Beata JastrzebskaPageof 776